laetrile

Drug Overview

Laetrile is a term used to describe a semi-synthetic form of amygdalin, a naturally occurring compound found in the seeds of many fruits, such as apricots, bitter almonds, and peaches. Historically, it has been promoted as an alternative cancer treatment. However, it is essential to understand that in the international medical community, it is not recognized as a standard “Smart Drug” or a proven “Targeted Therapy.”

While proponents in the mid-20th century referred to it as “Vitamin B17,” it is not actually a vitamin. In many regions, including the United States and Europe, its use is heavily restricted or banned for medicinal purposes due to a lack of evidence regarding its effectiveness and significant concerns regarding its safety.

• Generic Name: Amygdalin (purified form) or Laetrile.
• US Brand Names: None (Not an FDA-approved drug).
• Drug Class: Cyanogenic Glycoside.
• Route of Administration: Oral (tablets) or Intravenous (IV) injection.
• FDA Approval Status: Not Approved. It is illegal to sell or market Laetrile as a cancer treatment in the United States.

What Is It and How Does It Work? (Mechanism of Action)

To understand Laetrile, you must understand the chemistry of cyanide. Laetrile is made of four main parts: two parts sugar, one part benzaldehyde, and one part cyanide. Proponents of the drug suggest a theory involving the “selective release” of poison within cancer cells.

At the molecular level, the theorized (though medically unproven) process works as follows:

1. Enzymatic Activation: It was hypothesized that cancer cells contain high levels of an enzyme called beta-glucosidase. This enzyme is supposed to “unlock” the Laetrile molecule.
2. Cyanide Release: When beta-glucosidase breaks the molecule apart, it releases Hydrogen Cyanide (HCN) directly into the cell.
3. Mitochondrial Poisoning: Cyanide is a potent toxin that binds to cytochrome c oxidase, a protein in the mitochondria (the cell’s power plant). This prevents the cell from using oxygen, effectively “suffocating” it.
4. The Protection Theory: Proponents claimed that healthy cells contain another enzyme called rhodanese, which can neutralize cyanide. They believed cancer cells lacked this protector.

Medical Reality: Rigorous scientific testing has shown that beta-glucosidase is actually more common in the intestines and liver than in tumors, and rhodanese is present in both healthy and cancerous cells. This means the “poison” is often released in healthy parts of the body—like the gut—rather than inside the tumor.

FDA Approved Clinical Indications

Currently, there are no FDA-approved clinical indications for Laetrile. It is not recognized as a treatment for any medical condition by major health organizations.

Oncological Uses

• None. Extensive clinical trials by the National Cancer Institute (NCI) found no evidence that Laetrile shrinks tumors or extends life.

Non-Oncological Uses

• None. While historically used as a food supplement in some cultures, it has no recognized therapeutic use in modern medicine.

Dosage and Administration Protocols

Because Laetrile is not an approved medication, there are no “standard” medical doses. The following information represents doses used in historical or alternative clinical trials.

IMPORTANT: Dose adjustments for renal or hepatic insufficiency are not established. However, because the liver and kidneys are responsible for clearing toxins, any amount of cyanide is significantly more dangerous for patients with liver or kidney issues.

Clinical Efficacy and Research Results

Current research from 2020–2025 continues to support the conclusion that Laetrile is ineffective against cancer.

• Survival Rates: Systematic reviews of historical data (such as the 1982 NCI trial) show that Laetrile does not improve survival. In that study, out of 175 patients, only one met the criteria for a partial response, and that lasted only ten weeks.
• Disease Progression: Modern laboratory studies (2021–2023) using cancer cell lines have shown some cell death in test tubes, but these results have not translated to success in human patients.
• Numerical Data: A Cochrane Review concluded that the risk-to-benefit ratio is overwhelmingly negative, as the “treatment” carries a high risk of cyanide poisoning without evidence of anti-cancer activity.

Safety Profile and Side Effects

Black Box Warning:

WARNING: CYANIDE POISONING. Laetrile can cause life-threatening cyanide toxicity. The risk is significantly increased when taken orally, as bacteria in the gut release the cyanide from the drug. This can lead to coma, organ failure, and death.

Common Side Effects (>10%)

• Nausea and Vomiting: Often an early sign of toxicity.
• Headache: Caused by reduced oxygen in the brain.
• Dizziness: Feeling lightheaded or faint.

Serious Adverse Events

• Cyanide Toxicity: Symptoms include blue-tinted skin (cyanosis), low blood pressure, and drooping eyelids.
• Nerve Damage: Long-term use can lead to difficulty walking and loss of feeling in the limbs.
• Liver Damage: High doses can cause inflammation of the liver (hepatitis).

Management Strategies

• Immediate Discontinuation: Stop use at the first sign of headache or nausea.
• Emergency Care: If toxicity is suspected, emergency treatment with a Cyanide Antidote Kit (using sodium thiosulfate or hydroxocobalamin) is required immediately.

Research Areas

In the fields of Regenerative Medicine and Immunotherapy, researchers are looking at natural compounds for “sensitization.” Some early-stage lab research is exploring whether amygdalin derivatives could make certain tumors more sensitive to traditional radiation. However, this is strictly laboratory-based and is not ready for human use. Current research focuses more on finding safer, non-toxic ways to target the same mitochondrial pathways without using cyanide.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed

• Baseline Blood Cyanide Levels: To monitor for poisoning.
• Liver and Kidney Function Tests (LFTs/BUN/Cr): To check organ health.

Precautions During Treatment

• Dietary Restrictions: Avoid eating raw almonds, crushed fruit pits, or large amounts of sprouts, as these contain natural enzymes that increase the release of cyanide from Laetrile.
• Avoid High Vitamin C: Taking large amounts of Vitamin C with Laetrile can speed up the release of cyanide.

“Do’s and Don’ts” List

• Do consult with an oncologist about evidence-based treatments.
• Do inform your medical team if you have taken any form of amygdalin.
• Don’t use Laetrile as a replacement for conventional cancer therapy.
• Don’t give this substance to children, as they are much more susceptible to cyanide poisoning.

Legal Disclaimer

Standard medical information disclaimer: This guide is for informational purposes only and does not constitute medical advice. Laetrile is not an FDA-approved treatment. The use of this substance carries a high risk of cyanide poisoning. Always consult with a licensed oncologist or healthcare professional before making decisions about cancer treatment. Information is based on clinical data available as of 2026.